VEGFA-targeting Gene Therapy to Treat Retinal and Choroidal Neovascularization Diseases

NCT05099094 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

3

Enrollment

INDUSTRY

Sponsor class

Conditions

Neovascular Age-related Macular Degeneration
Diabetic Macular Edema
Retinal Vein Occlusion

Interventions

GENETIC: BD311

Sponsor

Shanghai BDgene Co., Ltd.

Collaborators

[object Object]